Enrica T. Tanda

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 250 citations · Full text

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone et al. · European Journal of Cancer · 2020 · 111 citations

Advanced Cancer, Medicine, Immune Checkpoint Inhibitors +9

The treatment of advanced melanoma: Current approaches and new challenges

Andrea Boutros, Elena Croce, Marco Ferrari et al. · Critical Reviews in Oncology/Hematology · 2024 · 108 citations · Full text

Tumor Biology, Melanoma Treatment, Pd-l1 Expression +14

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary et al. · Clinical Cancer Research · 2023 · 67 citations · Full text

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

Olga Nigro, Graziella Pinotti, Federica De Galitiis et al. · European Journal of Cancer · 2020 · 61 citations

Cancer Immunosurveillance, Autoimmune Disease, Medicine +12